6RMK
Bacteriorhodopsin, dark state, cell 2, refined using the same protocol as sub-ps time delays
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | FREE ELECTRON LASER |
Source details | SLAC LCLS BEAMLINE CXI |
Synchrotron site | SLAC LCLS |
Beamline | CXI |
Temperature [K] | 293 |
Detector technology | PIXEL |
Collection date | 2017-08-06 |
Detector | CS-PAD CXI-2 |
Wavelength(s) | 1.26 |
Spacegroup name | P 63 |
Unit cell lengths | 62.100, 62.100, 110.500 |
Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
Resolution | 20.441 - 1.800 |
R-factor | 0.2439 |
Rwork | 0.243 |
R-free | 0.24920 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 5b6v |
RMSD bond length | 0.006 |
RMSD bond angle | 0.933 |
Data reduction software | CrystFEL |
Data scaling software | CrystFEL |
Phasing software | PHASER |
Refinement software | PHENIX ((dev_2645: ???)) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 20.444 | 1.850 |
High resolution limit [Å] | 1.800 | 1.800 |
Number of reflections | 22403 | 1140 |
<I/σ(I)> | 9.9 | |
Completeness [%] | 100.0 | |
Redundancy | 476 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | LIPIDIC CUBIC PHASE | 293 | 32% (W/V) PEG 2000, 0.1 M K2HPO4 /NAH2PO4, IN HAMILTON SYRINGES, PH 5.6, LIPIDIC CUBIC PHASE, |